Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rishi Paliwal, Shivani Rai Paliwal, Rameshroo Kenwat, Balak Das Kurmi & Mukesh Kumar Sahu. (2020) Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opinion on Therapeutic Patents 30:3, pages 179-194.
Read now
Read now
Articles from other publishers (22)
Uttam Dutta, Gaurav Prakash, Kirti Devi, Kongkona Borah, Xinglong Zhang & Debabrata Maiti. (2023)
Directing group assisted
para
-selective C–H alkynylation of unbiased arenes enabled by rhodium catalysis
. Chemical Science 14:41, pages 11381-11388.
Crossref
Crossref
Lars Schlotawa, Karolina Tyka, Matthias Kettwig, Rebecca C Ahrens‐Nicklas, Matthias Baud, Tea Berulava, Nicola Brunetti‐Pierri, Alyssa Gagne, Zackary M Herbst, Jean A Maguire, Jlenia Monfregola, Tonatiuh Pena, Karthikeyan Radhakrishnan, Sophie Schröder, Elisa A Waxman, Andrea Ballabio, Thomas Dierks, André Fischer, Deborah L French, Michael H Gelb & Jutta Gärtner. (2023) Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. EMBO Molecular Medicine 15:3.
Crossref
Crossref
梓琪 唐. (2023) Research Progress of Hand Eczema. Advances in Clinical Medicine 13:01, pages 555-563.
Crossref
Crossref
Yan Gao, Rui Xiao, Bingbing Feng, Zhiyi Bian, Han Zhang, Gangguo Zhu, Yanan Wang & Zheliang Yuan. (2023) Metal-free Lewis-acid-catalyzed divergent trifluoromethylselenolation of alkynes: construction of α-trifluoromethylselenolated ketones and alkynes. Organic Chemistry Frontiers.
Crossref
Crossref
Rajesh S. Jadon, Pratap S. Jadon, Vivek Bhadauria, Vikas Sharma, Sudhir Bharadwaj, Manoj Sharma, Kavita R. Gajbhiye & Virendra Gajbhiye. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers
265
282
.
Shiu-Wan Chan, Talha Shafi & Robert C. Ford. (2021) Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step. Viruses 13:11, pages 2306.
Crossref
Crossref
Pavithra Venkataswamy, Sowmya Samudrala Venkatesiah, Roopa S. Rao, Spoorthi Ravi Banavar, Shankargouda Patil, Dominic Augustine & Vanishri C. Haragannavar. (2020) Immunohistochemical expression of Tazarotene‐induced Gene 3 in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 50:4, pages 403-409.
Crossref
Crossref
Agata Kryczyk-Poprawa, István Zupkó, Péter Bérdi, Paweł Żmudzki, Justyna Popiół, Bożena Muszyńska & Włodzimierz Opoka. (2020) Photostability Testing of a Third-Generation Retinoid—Tazarotene in the Presence of UV Absorbers. Pharmaceutics 12:9, pages 899.
Crossref
Crossref
Arup Mondal, Hao Chen, Lea Flämig, Philipp Wedi & Manuel van Gemmeren. (2019) Sterically Controlled Late-Stage C–H Alkynylation of Arenes. Journal of the American Chemical Society 141:47, pages 18662-18667.
Crossref
Crossref
Alexandre Morin, Mélissa Simard, Geneviève Rioux, Alexe Grenier, Sophie Morin & Roxane Pouliot. (2019) Application of an In Vitro Psoriatic Skin Model to Study Cutaneous Metabolization of Tazarotene. Processes 7:12, pages 871.
Crossref
Crossref
Lingjun Li, Mengli Zhang, Pengcheng Ma & Kun Qian. (2019) Development of a simple method for simultaneous determination of tazarotene and betamethasone dipropionate and their metabolites using LC–MS method and its application to dermatopharmacokinetic study. Biomedical Chromatography 33:8.
Crossref
Crossref
Erica S. Tarabadkar & Michi M. Shinohara. (2019) Skin Directed Therapy in Cutaneous T-Cell Lymphoma. Frontiers in Oncology 9.
Crossref
Crossref
Rituparna Maiti, Chandra Sekhar Sirka, M. A. Ashique Rahman, Anand Srinivasan, Sansita Parida & Debasish Hota. (2017) Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial. Clinical Drug Investigation 37:11, pages 1083-1091.
Crossref
Crossref
Biswanath Behera, Laxmisha Chandrashekar, Nidhi Singh, Devinder Mohan Thappa & Debasis Gochhait. (2017) Lamellar ichthyosis associated bilateral pseudoainhum of fingers and toes successfully treated with tazarotene. Dermatologic Therapy 30:5, pages e12516.
Crossref
Crossref
R. S. Foti, N. Isoherranen, A. Zelter, L. J. Dickmann, B. R. Buttrick, P. Diaz & D. Douguet. (2016) Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1. Journal of Pharmacology and Experimental Therapeutics 357:2, pages 281-292.
Crossref
Crossref
Ahmed M. Mansour. (2016) Tazarotene copper complexes: Synthesis, crystal structure, DFT and biological activity evaluation. Polyhedron 109, pages 99-106.
Crossref
Crossref
Anthony P Raphael, Gabriela Garrastazu, Fabio Sonvico & Tarl W Prow. (2015) Formulation design for topical drug and nanoparticle treatment of skin disease. Therapeutic Delivery 6:2, pages 197-216.
Crossref
Crossref
Tiffany M. Scharadin & Richard L. Eckert. (2014) TIG3: An Important Regulator of Keratinocyte Proliferation and Survival. Journal of Investigative Dermatology 134:7, pages 1811-1816.
Crossref
Crossref
John Koo, Ethan Levin, Argentina Leon, Jashin Wu & Mark LebwohlShannon Famenini, Eric Sako & Jashin Wu. 2014. Mild to Moderate Psoriasis, Third Edition. Mild to Moderate Psoriasis, Third Edition
9
20
.
Michael Jarratt, Cary P. Werner & Alessandra B. Alió Saenz. (2013) Tazarotene Foam versus Tazarotene Gel: A Randomized Relative Bioavailability Study in Acne Vulgaris. Clinical Drug Investigation 33:4, pages 283-289.
Crossref
Crossref
Valerio ChiurchiùMauro Maccarrone. (2011) Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities. Antioxidants & Redox Signaling 15:9, pages 2605-2641.
Crossref
Crossref
Rebecca Nguyen & John Su. (2011) Treatment of acne vulgaris. Paediatrics and Child Health 21:3, pages 119-125.
Crossref
Crossref